TP53 and lung cancer: In lung cancer patients, in agreement with our results, Tseng et al. have demonstrated that those patients with positive SIRT1, low acetylated TP53 and low HIC1 expression have worse prognosis, although the prognostic value of SIRT1 alone was not analyzed in this study [34].